Selective Serotonin Reuptake Inhibitors, are They All Equal? A Pharmacoepidemiological Study

Péron E^1,2, Hardouin JB^2,3, Sébille V^2,3, Feuillet F^2,3, Wainstein L^1,2, Chaslerie A⁴, Pivette J⁴, Jolliet P^1,2 and Victorri-Vigneau C^1,2*

¹Centre for Evaluation and Information on Drug-Addictovigilance, Clinical Pharmacology, Hôtel Dieu, Institute of Biology, 9 Quai Moncousu, 44093, Nantes Cedex 1, France

²EA 4275 Biostatistics, Pharmacoepidemiology and Subjective Health Measures, Faculty of Pharmaceutical and Biological Sciences, Nantes, France

³Biometrics Platform, Promoting Clinical Research Unit, CHU Nantes, France

⁴Regional Department of Health Insurance Medical Service of the Loire, Nantes, France